Decoy Therapeutics — Valuation, Funding & Investors

Recent changes

Jul 10, 2026Jul 10, 2026IPO $3.5M SEC EDGAR
Jul 10, 2026Jul 10, 2026Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE Pulse story

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Jul 10, 2026	ipo	$3.5M	—		Pulse story

Latest Pulse

Jul 10, 2026Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPEDecoy Therapeutics filed its second S-1 in a month tied to a private placement that could deliver up to $21 million in milestone-based warrant proceeds contingent on trial results and shareholder approval.→

Coverage Timeline

newest first

Jul 10, 2026IPODecoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE~$3.5M base + up to $21M contingent→

All Coverage

IPO· Jul 10, 2026

Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE

IPO~$3.5M base + up to $21M contingent

Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE

Decoy Therapeutics filed its second S-1 in a month tied to a private placement that could deliver up to $21 million in milestone-based warrant proceeds contingent on trial results and shareholder approval.

Jul 10, 2026

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics

Sources & methodologyshow

Where these figures come from

SEC EDGARprimary source1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction